341 related articles for article (PubMed ID: 33026777)
1. Atopic Dermatitis and the Role of the Skin Microbiome in Choosing Prevention, Treatment, and Maintenance Options.
Baldwin H; Aguh C; Andriessen A; Benjamin L; Ferberg AS; Hooper D; Jarizzo JL; Lio PA; Tlougan B; Woolery-Lloyd HC; Zeichner J
J Drugs Dermatol; 2020 Oct; 19(10):935-940. PubMed ID: 33026777
[TBL] [Abstract][Full Text] [Related]
2. Evidence of Barrier Deficiency in Rosacea and the Importance of Integrating OTC Skincare Products into Treatment Regimens.
Baldwin H; Alexis AF; Andriessen A; Berson DS; Farris P; Harper J; Lain E; Marchbein S; Stein Gold L; Tan J
J Drugs Dermatol; 2021 Apr; 20(4):384-392. PubMed ID: 33852244
[TBL] [Abstract][Full Text] [Related]
3. Topical ozone therapy restores microbiome diversity in atopic dermatitis.
Zeng J; Dou J; Gao L; Xiang Y; Huang J; Ding S; Chen J; Zeng Q; Luo Z; Tan W; Lu J
Int Immunopharmacol; 2020 Mar; 80():106191. PubMed ID: 31986325
[TBL] [Abstract][Full Text] [Related]
4. Skin bacterial transplant in atopic dermatitis: Knowns, unknowns and emerging trends.
Hendricks AJ; Mills BW; Shi VY
J Dermatol Sci; 2019 Aug; 95(2):56-61. PubMed ID: 31395434
[TBL] [Abstract][Full Text] [Related]
5. From Probiotic to Prebiotic Using Thermal Spring Water.
Zeichner J; Seite S
J Drugs Dermatol; 2018 Jun; 17(6):657-662. PubMed ID: 29879253
[TBL] [Abstract][Full Text] [Related]
6. Effects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties.
Capone K; Kirchner F; Klein SL; Tierney NK
J Drugs Dermatol; 2020 May; 19(5):524-531. PubMed ID: 32484623
[TBL] [Abstract][Full Text] [Related]
7. The ABC Topical Management of Atopic Dermatitis in Philippines: Expert Recommendations.
Lavadia AM; Cumagun AT; Palmero L; Ramos NS; Tan CJ
J Drugs Dermatol; 2021 Jan; 20(1):84-87. PubMed ID: 33400416
[TBL] [Abstract][Full Text] [Related]
8. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents.
Luger T; Amagai M; Dreno B; Dagnelie MA; Liao W; Kabashima K; Schikowski T; Proksch E; Elias PM; Simon M; Simpson E; Grinich E; Schmuth M
J Dermatol Sci; 2021 Jun; 102(3):142-157. PubMed ID: 34116898
[TBL] [Abstract][Full Text] [Related]
9. The Role of the Microbiome and Microbiome-Derived Metabolites in Atopic Dermatitis and Non-Histaminergic Itch.
Li W; Yosipovitch G
Am J Clin Dermatol; 2020 Sep; 21(Suppl 1):44-50. PubMed ID: 32910440
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Nonprescription Moisturizers for Atopic Dermatitis: An Updated Review of Clinical Evidence.
Hebert AA; Rippke F; Weber TM; Nicol NH
Am J Clin Dermatol; 2020 Oct; 21(5):641-655. PubMed ID: 32524381
[TBL] [Abstract][Full Text] [Related]
11. The Microbiome and Atopic Dermatitis: A Review.
Pothmann A; Illing T; Wiegand C; Hartmann AA; Elsner P
Am J Clin Dermatol; 2019 Dec; 20(6):749-761. PubMed ID: 31444782
[TBL] [Abstract][Full Text] [Related]
12. The benefit of a ceramide-linoleic acid-containing moisturizer as an adjunctive therapy for a set of xerotic dermatoses.
Yang Q; Liu M; Li X; Zheng J
Dermatol Ther; 2019 Jul; 32(4):e13017. PubMed ID: 31276265
[TBL] [Abstract][Full Text] [Related]
13. Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis.
Diluvio L; Dattola A; Cannizzaro MV; Franceschini C; Bianchi L
G Ital Dermatol Venereol; 2019 Feb; 154(1):32-36. PubMed ID: 30207438
[TBL] [Abstract][Full Text] [Related]
14. First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis.
Myles IA; Earland NJ; Anderson ED; Moore IN; Kieh MD; Williams KW; Saleem A; Fontecilla NM; Welch PA; Darnell DA; Barnhart LA; Sun AA; Uzel G; Datta SK
JCI Insight; 2018 May; 3(9):. PubMed ID: 29720571
[TBL] [Abstract][Full Text] [Related]
15. Balance between beneficial microflora and Staphylococcus aureus colonisation: in vivo evaluation in patients with atopic dermatitis during hydrotherapy.
Bourrain M; Ribet V; Calvez A; Lebaron P; Schmitt AM
Eur J Dermatol; 2013; 23(6):786-94. PubMed ID: 24280310
[TBL] [Abstract][Full Text] [Related]
16. Association between barrier impairment and skin microbiota in atopic dermatitis from a global perspective: Unmet needs and open questions.
Darlenski R; Kozyrskyj AL; Fluhr JW; Caraballo L
J Allergy Clin Immunol; 2021 Dec; 148(6):1387-1393. PubMed ID: 34688495
[TBL] [Abstract][Full Text] [Related]
17. American Academy of Dermatology Guidelines for Managing Atopic Dermatitis.
Robinson L; Strowd LC
Adv Exp Med Biol; 2024; 1447():217-225. PubMed ID: 38724796
[TBL] [Abstract][Full Text] [Related]
18. Atopic dermatitis: Pathophysiology, microbiota, and metabolome - A comprehensive review.
Mohammad S; Karim MR; Iqbal S; Lee JH; Mathiyalagan R; Kim YJ; Yang DU; Yang DC
Microbiol Res; 2024 Apr; 281():127595. PubMed ID: 38218095
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Cutaneous Microbiota in Atopic Dermatitis by Coal Tar via AHR-Dependent Induction of Antimicrobial Peptides.
Smits JPH; Ederveen THA; Rikken G; van den Brink NJM; van Vlijmen-Willems IMJJ; Boekhorst J; Kamsteeg M; Schalkwijk J; van Hijum SAFT; Zeeuwen PLJM; van den Bogaard EH
J Invest Dermatol; 2020 Feb; 140(2):415-424.e10. PubMed ID: 31344386
[TBL] [Abstract][Full Text] [Related]
20. The microbiome in patients with atopic dermatitis.
Paller AS; Kong HH; Seed P; Naik S; Scharschmidt TC; Gallo RL; Luger T; Irvine AD
J Allergy Clin Immunol; 2019 Jan; 143(1):26-35. PubMed ID: 30476499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
